Characteristic | Total (n = 59) | Advanced VTT (n = 10) | Early VTT (n = 49) | P value |
---|---|---|---|---|
Clinical parameters | ||||
 Age (ys) | 54.8 ± 12.8 | 56.0 ± 15.6 | 54.6 ± 12.3 | 0.750a |
 Gender |  |  |  | 0.254c |
  Male | 42(71.2%) | 9(90.0%) | 33(67.3%) |  |
  Female | 17(28.8%) | 1(10.0%) | 16(32.7%) |  |
 Symptoms |  |  |  | 0.333c |
  Presence | 50(84.7%) | 10(100.0%) | 40(81.6%) |  |
  Absence | 9(15.3%) | 0(0.0%) | 9(18.4%) |  |
 BMI (kg/m2) | 25.2 ± 3.6 | 25.2 ± 2.9 | 25.2 ± 3.8 | 0.999a |
PET/CT parameters | ||||
 Primary tumor SUVmax | 6.6(4.3–10.4) | 8.7(5.9–10.7) | 6.0(4.2–10.8) | 0.203b |
 VTT SUVmax | 3.7(2.5–6.1) | 6.5(5.3–8.8) | 3.4(2.5–5.4) | 0.002b |
 Primary tumor size (cm) | 8.8 ± 2.5 | 9.4 ± 3.3 | 8.7 ± 2.4 | 0.450a |